The pace of advancement in Precision Medicine has been tremendous and has resulted in far greater outcomes for patients than some thought possible 20 years ago. However, with the increasing number of biomarkers and the technological advancement in testing, this has created challenges for physicians to keep pace, with a recent Journal of Clinical Oncology (JCO) publication stating that physicians encounter issues when interpreting genomic test results, leading to patients receiving broad spectrum therapies which are less efficacious and with increased side effects.
The ability to engage physicians with appropriate education at the right time is critical for the life science industry in both routine clinical practice and clinical trial setting, to support the adoption of Precision Medicine, which has demonstrated superior outcomes and cost effectiveness. DXRX Signal delivers an actionable alert of a testing behavior that enables industry to engage physicians before treatment decisions have been made. By receiving DXRX Signal alerts and engaging physicians within this timeframe, biopharmaceutical companies can maximize the effectiveness of brand sales and marketing activities, resulting in commercial success, with patients getting the treatment they deserve. DXRX Signal, powered by 494 labs and our leading experts in Precision Medicine and Machine Learning, can specifically design alerts for a variety of clinical situations, for example, 2L setting based on multiple tracked testing events or risk stratification status based on multiple biomarker results.
Utilizing lab data is critical for providing the earliest identification of physicians with potentially eligible patients and therefore has the greatest impact on the adoption of Precision Medicine. DXRX Signal Alerts have been successfully employed in several settings including oncology, rare diseases, auto-immune, cardiovascular, and infectious diseases.
Ready to add Precision to your data strategy? Get in touch today to schedule a demo. Click here: Request a Demo - Diaceutics
